Fundraising Fox
Emblok
Tampa, US · Founded 2025 · Delaware corporation · 1 known investors
Find your way into Emblok
Sign up to see every warm intro you have to Emblok
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emblok team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
Founders & leadership
Board
AJ
Alan J. SimonianBoard director
WM
William M. MerhiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2026
▶$6MraisedJun 2026 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bradley BrownExecutive Officer
- William M. MerhiDirector
- Alan J. SimonianDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
EmbolineEmboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Companies working in the same space as Emblok.
In the news
Frequently asked questions
- What does Emblok do?
- Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
- Who are Emblok's investors?
- Emblok's investors include JStar Capital Investments.
- How much funding has Emblok raised?
- Emblok has disclosed $6M raised across 1 round.
- Where is Emblok headquartered?
- Emblok is headquartered in Tampa, US.